Abstracts: ND09; 688 / 1; 6033 / 15; 6501 / 18 Berlin, Germany, and San Diego, CA, USA, April 3, 2023 – Bayer and Vividion Therapeutics, Inc. (Vividion) will present the latest research on their advancing oncology portfolio at the upcoming American Association for Cancer Research (AACR) 2024 Annual Meeting, taking place from April 5-10, […] The post Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting appeared first on Vividion Therapeutics.
